Agoracom interviews CEOs of small cap companies. In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Cardiol Therapeutics (TSX:CRDL) President and CEO, David Elsley. Cardiol Therapeutics $CRDL.ca $CRTPF is a groundbreaking, clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels). ● The company […]